Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cross-reactive T-cell epitopes of HIV, SIV, and FIV for vaccines in humans and cats

Cross-reactive T-cell epitopes of HIV, SIV, and FIV for vaccines in humans and cats

US Patent 10758609 · Granted Sep 1, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Immunogenic compositions comprising FIV and HIV gag antigens2021
Cross-reactive T cell epitopes of HIV, SIV, and FIV for vaccines in humans and c2021
Cross-reactive T cell epitopes of HIV, SIV, and FIV for vaccines in humans and c2018
Materials and methods for immunizing against FIV infection2014
Method for inducing cross-reactive immune responses to the human immunodeficienc2012
Materials and methods for immunizing against FIV infection2010
Multi-subtype FIV vaccines2007
Multi-subtype FIV vaccines2007
Combination therapy for treatment of FIV infection2005
Multi-subtype FIV vaccines2003
Multi-subtype FIV vaccines2003
Multi-subtype FIV vaccines2002